ixlayer

ixlayer is heading to #ViVE2025! We’re excited to join the conversation at ViVE, where the brightest minds in healthcare and digital transformation come together to shape the future of the industry. Our team will be available for 1:1 meetings to discuss how ixlayer provides a seamless and supported patient journey for our biopharma clients. Whether you’re looking to enhance your direct-to-patient strategy, improve access to care, or explore partnership opportunities, we’d love to chat! Let’s connect and explore how we can collaborate to drive better patient outcomes through technology. Drop us a message or comment below to schedule a time to meet! #HealthTech #DigitalHealth #Diagnostics #Innovation #PatientCentricCare #ixlayer

Who has one of the Top Health Tech CEOs to Watch in 2025? We do! Congrats to Pouria Sanae, ixlayer’s co-founder and CEO. Named to this list by Forbes and Senior Executive, this recognition highlights Pouria’s leadership in driving patient-centric innovation and transforming the healthcare experience through technology. Under his guidance, ixlayer continues reinventing the traditional patient journey with support from our #biopharma clients by providing a simplified, unified and accelerated connection to care. As the healthcare industry evolves, ixlayer remains at the forefront, ensuring that technology and innovation lead the way in improving health outcomes and streamlining clinical workflows. We’re proud to see Pouria’s impact recognized, and we’re excited for what’s ahead! Congratulations, Pouria! Read more about this recognition here: https://lnkd.in/eJ6qSGdE #HealthTech #Leadership #Innovation #DigitalHealth #HealthcareTransformation #ixlayer

I recently joined a panel on direct-to-patient programs, where we explored how these programs can go beyond Rx access and telehealth. We discussed how technology is enabling continuous assessment between clinic visits and what it takes to integrate these tools into provider workflows. As well as the vital role of ecosystem partners in creating a seamless, brand-agnostic patient journey.

In our recent webinar in collaboration with The DHC Group, Exploring Best Practices for Biopharma DTP Implementation, panelists Matthew Walsh, Nandini Nayar, Eric McCulley, Mark Gaydos, and Chad Maeder clarified the best practices and misconceptions around direct-to-patient (DTP) programs. Read the key takeaways on the ixlayer blog, broken into two, easily digestible parts. Read part one today, and keep an eye out for part two next week. https://lnkd.in/ew5zzV2Z #Directtopatient #healthcareinnovation #pharma

ixlayer is excited to be named to the Digital Health New York 100, joining the ranks of past winners Capsule, Maven Clinic, Oscar Health, Ro, Sword Health, Talkiatry, Talkspace and Zocdoc. Read more in today's press release: https://lnkd.in/e_wtDkut

Our recent webinar explored best practices and common misconceptions around DTP programs, breaking down how they operate and drive impact. Our expert panel shared insights on patient expectations, early intervention, telehealth, lab testing, prescription fulfillment, and navigating compliance challenges. If you couldn’t join us live, you can now watch the full discussion on demand. Don’t miss the opportunity to gain key perspectives from Matthew Walsh, Mark Gaydos, Eric McCulley, Chad Maeder, and Nandini Nayar on optimizing DTP initiatives and improving patient outcomes. 🎥 Watch here: https://lnkd.in/ef7wWVjq

Early detection of Type 1 Diabetes (T1D) can change lives, yet too many people are unaware of their risk. That’s why we’re proud that ixlayer helps power Screening Central, Sanofi's platform for T1D autoantibody screening. This launch helps to expand access to early screening and empower individuals with the information they need. #ScreenForType1 #ScreeningCentral #DigitalHealth #EarlyDetection

Digital Tools Among Older Adults: A new analysis from JAMA Network Open of the 2021 National Poll on Healthy Aging survey delivered an updated look at the use of digital health technologies among older adults. Data from 2,110 adults (avg. 64 years old) showed that 65% used a patient portal, 49% used telehealth, and 44% used mobile health apps. Find out how ixlayer is improving the virtual patient experience to simplify and accelerate the connection to care at www.ixlayer.com #HealthcareInnovation #DirectToPatient #PharmaLeadership https://lnkd.in/eMCrM7V3

"Pharma isn’t causing the shift towards proactive consumer health management and technology adoption, they’re adapting to it and supporting it because ultimately, better care will be delivered with it." Read ixlayer CEO Pouria Sanae’s op-ed piece in Pharmaceutical Executive on why pharma’s direct-to-patient approach should be applauded. Visit www.ixlayer.com to learn how our unified direct-to-patient platform, helps biopharma transform the patient experience. #HealthcareInnovation #DirectToPatient #PharmaLeadership https://lnkd.in/eTSfKTfg

There's a transformative shift in pharma marketing as the industry evolves from "click-for-doctor" solutions to comprehensive direct-to-patient healthcare models. We are excited to be a part of this evolution working to make healthcare more accessible and effective for all. Here's an in-depth review of the playing field by Beth Snyder Bulik of Marketing & Pharma. We're proud to see ixlayer's Debra Harris and Matthew Walsh featured alongside other industry leaders like EVERSANA INTOUCH, Ro, UpScriptHealth, Eli Lilly and Company , and Pfizer!  Check out the full article here: https://lnkd.in/eHKXATVE #healthcaremarketing #pharmamarketing #industrytrends